期刊文献+

APOPTOTIC AND PROLIFERATIVE ACTIVITY IN OVARIAN BENIGN,BORDERLINE AND MALIGNANT TUMORS

APOPTOTIC AND PROLIFERATIVE ACTIVI TY IN OVARIAN BENIGN,BORDERLINE AND MALI GNANT TUMORS
下载PDF
导出
摘要 Objective.To determine the apoptotic and proliferative activities in various ovarian epithelial tumors.Methods.Formalin-fixed,paraffin-embedded tissues of 86ovarian epithelial tu mors,including 52adenocarcino-mas,23borderline tumors and 11cystadenomas,were retrieved.Apoptoti c(AI )and proliferative(PI )index were estimated using the monoclonal antibodies:M30,Ki-67and Ki-S1in t hese tumors.Quantitative assess-ment of AI and PI was estimated by calc ulating the percentage of positive c ells among no less than 1000tumor cells.Results.Statistically significant differe nce in AI was found between benign and borderline tumors or carcino-mas(P=0.028,0.001,respectively).Significant differences in PI,as a ssessed by both Ki-67and topo IIα,were demonstrated between carcinom as and benign or borderline tumors(both P<0.001).Benign tumors had both low PI and AI;borderline tumors had lower PI but higher AI,while aden ocarcinomas had both high prolifera-tive and high apoptotic rates.Among borderline tumors,serous tumors had significantly lower AI and higher PI than mucinous ones.Conclusions.The results suggest that apoptotic a nd proliferative activities play im portant roles in the pathogene-sis and development of ovarian borderline and malignant tumors.The high apoptotic rate in borderline tumor m ay explain its relatively indolent beh avior while the high proliferative r ate in carcinomas tends to explain its aggres-sive behavior.
出处 《Chinese Medical Sciences Journal》 CAS CSCD 2002年第2期106-111,共6页 中国医学科学杂志(英文版)
关键词 KI-67 M30 topoisomerase IIα ovarian epithelial tumor 卵巢肿瘤 良性肿瘤 恶性肿瘤 中间型肿瘤 细胞凋亡 细胞增殖活性
  • 相关文献

参考文献12

  • 1[1]Schink JC.Current initial therapy of stage Ⅲ to Ⅳ ovarian carcinoma: challenge for managed care.Semin Oncol 1999;26(Suppl 1): 2- 7. 被引量:1
  • 2[2]Elias JM.Cell proliferation indexes: a biomark in solid tumors.Biotech Histochem 1997; 72(2): 78- 85. 被引量:1
  • 3[3]Berger JM,et al.Structure and mechanism of DNA topoisomerase II.Nature 1996;379: 225- 32. 被引量:1
  • 4[4]Solary E,et al.Proteases,proteolysis,and apoptosis.Cell Biol Toxicol 1998; 14: 121- 32. 被引量:1
  • 5[5]Leers MP,et al.Immunocytochemical detection and mapping of a cytokeratin 18 neo epitope exposed during early apoptosis.J Pathol 1999; 187: 567- 72. 被引量:1
  • 6[6]Chan WY,Cheung KK,Schorge JO,et al.Bcl 2 and p53 protein expression,apoptosis and p53 mutation in human epithelial ovarian cancers.Am J Pathol 2000; 156: 409- 17. 被引量:1
  • 7[7]Chiu PM,Ngan HYS,Khoo US,et al.Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome - - assessment by M30 cytodeath antibody which recognizes caspase cleavage site within cytokeratin 18.Histopathology 2001; 38:243- 9. 被引量:1
  • 8[8]Gerdes J,Li L,Schlueter C,et al.Immunohistochemical and molecular biologic characterization of the cell proliferation associated nuclear antigen that is defined by monoclonal antibody Ki 67.Am J Pathol 1991;138: 867- 73. 被引量:1
  • 9[9]Downes CS,et al.A topoisomerase II- dependent G2 cycle checkpoint in mammalian cells.Nature 1994; 372: 467- 70. 被引量:1
  • 10[10]Tanoguchi K,et al.Immunohistochemical and two- parameter flow cytometric studies of DNA topoisomerase IIα in human epithelial ovarian carcinoma and germ cell tumor.Mod Pathol 1998; 11: 186- 93. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部